| 注册
首页|期刊导航|现代中医药|当归治疗2型糖尿病心肌病的潜在作用机制及研究进展

当归治疗2型糖尿病心肌病的潜在作用机制及研究进展

徐杰 牛屹泽 黄蕊 武春宇

现代中医药2026,Vol.46Issue(3):39-44,6.
✕
现代中医药2026,Vol.46Issue(3):39-44,6.DOI:10.13424/j.cnki.mtcm.2026.03.006

当归治疗2型糖尿病心肌病的潜在作用机制及研究进展

The Potential Mechanism and Research Progress of the Treatment of Type 2 Diabetic Cardiomyopathy

徐杰 1牛屹泽 1黄蕊 1武春宇1

作者信息

  • 1. 甘肃省药品监督管理局审核查验中心/甘肃省疫苗检查中心,甘肃 兰州 730000
  • 折叠

摘要

Abstract

With the aging of society,the prevalence of diabetes-a common age-related metabolic disorder-has been steadily increasing.As a consequence,the incidence of diabetic cardiomyopathy(DCM),one of its major complications,has also risen significantly.DCM represents the most prevalent cardiovascular complication in patients with type 2 diabetes mel-litus(T2DM),characterized by structural and functional myocardial abnormalities independent of coronary artery disease or hypertension.This condition not only serves as a critical factor in cardiac impairment and heart failure among diabetic pa-tients but also constitutes a specific myocardial injury distinct from secondary damage caused by coronary artery disease.The pathogenesis of DCM typically involves inflammatory aging,oxidative stress,mitochondrial dysfunction,and metabolic dis-turbances.The traditional Chinese herb Angelica sinensis(Danggui)has demonstrated potential therapeutic value for DCM due to its diverse pharmacologically active components.This review elucidates the pathological mechanisms of DCM,the pri-mary active constituents of Angelica sinensis,and their mechanisms in ameliorating DCM,thereby providing novel insights into the relationship between diabetic cardiomyopathy and Angelica sinensis treatment.

关键词

糖尿病心肌病/当归/作用机制/研究进展

Key words

diabetic cardiomyopathy/angelica sinensis/mechanism of action/research progress

分类

医药卫生

引用本文复制引用

徐杰,牛屹泽,黄蕊,武春宇..当归治疗2型糖尿病心肌病的潜在作用机制及研究进展[J].现代中医药,2026,46(3):39-44,6.

基金项目

甘肃省药品科研项目(2023QSMPA075) (2023QSMPA075)

现代中医药

1672-0571

访问量1
|
下载量0
段落导航相关论文